by Michelle Edwards at UncoverDC
Dr. Michael Yeadon, who left Pfizer in 2011 as Vice President and Chief Scientist for Allergy and Respiratory, has spent more than 30 years in some of the world’s largest pharmaceutical companies guiding new research in medicines. After leaving Pfizer, Dr. Yeadon founded Ziarco, a biotech company he sold to Novartis in 2017. Holding a degree in biochemistry and toxicology and a research-based Ph.D. in respiratory pharmacology, while at Pfizer, Yeadon held the senior-most research position in his field.
Last November, when Pfizer announced that its coronavirus vaccine was “90% effective in preventing COVID-19,” Emergency Use Authorization was granted from the Food and Drug Administration within weeks. Upon hearing this news, Dr. Yeadon, whose professional goal has always been to address unmet medical needs using ALL modes of new medical treatments as long as they are proven safe, immediately warned:
“There is absolutely no need for vaccines to extinguish the pandemic. I’ve never heard such nonsense talked about vaccines. You do not vaccinate people who aren’t at risk from a disease. You also don’t set about planning to vaccinate millions of fit and healthy people with a vaccine that hasn’t been extensively tested on human subjects.”…
Continue Reading